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ABSTRACT Previous studies (Miskin, R., T. G . Easton, and E. Reich, 1970, Cell. 15:1301-1312)
have shown that sarcoma virus transformation and tumor promoters reduced the cell surface
concentration of acetylcholine receptors (AChR) in differentiating chick embryo myogenic
cultures. Both of these agents also induced high rates of plasminogen activator (PA) synthesis
in myogenic cultures (Miskin, R., T. G. Easton, A. Maelicke, and E. Reich, 1978, Cell. 15:1287-
1300), and the present work was performed to establish whether proteolysis might significantly
affect receptor metabolism .
Proteolysis in myogenic cultures was modulated by one or more of the following: stimulation
of PA synthesis, direct addition of plasmin, removal of plasminogen, or addition of plasmin
inhibitors. The results were: (a) When the rates of proteolysis were raised either by addition of
plasmin or by stimulating PA synthesis in the presence of plasminogen, both the steady-state
concentration and the half-life of surface AChR decreased, but the rate of receptor synthesis
was unaffected. (b) The magnitude of these effects, and their dependence on added plasmin-
ogen, indicated that proteolysis initiated by plasminogen activation could account almost
entirely for the reduction in receptor half-life produced by sarcoma virus transformation and
phorbol ester. (c) The rate of receptor synthesis, which is also reduced by viral transformation
and tumor promoters, was not modified by proteolysis; hence plasmin action may be respon-
sible for a large part, but not all of the change in surface receptor under these conditions. (d)
The plasmin catalysed changes in receptor parameters appear to occur in response to modified
membrane metabolism resulting from proteolysis of surface components other than AChR
itself.
The acetylcholine receptor (AChR) in differentiating myogenic
cultures provides an accessible and attractive experimental
system for analyzing many parameters ofmembrane structure
and function. The receptor is well-characterized chemically,
pharmacologically, and metabolically, and it can be measured
accurately by use of specific, high-affinity, radioactive neuro-
toxins. As a protein that mediates transmembrane signaling
and local permeability, the AChR may serve as a model for
other integral membrane structuressuch as hormone receptors,
and it may also reflect diverse aspects of surface membrane
metabolism.
Previous studies of differentiating myogenic cultures have
established a correlation between plasminogen activator (PA)
production and the rate of acetylcholine receptor (AChR)
degradation: conditions associated with elevated PA produc-
tion, such as sarcoma virus transformation, exposure to tumor-
promoting phorbol esters, or early stages of culture, uniformly
accelerated AChR degradation and reduced receptor half-life
(14, 15). These results, derived from cultures maintained and
propagated in plasminogen-containing media, suggested that
proteolysis by plasmin could modulate the metabolism of cell
surface structures. This possibility could be tested experimen-
tally and it prompted the work reported here.
To characterize the influence of plasmin on AChR metabo-
lism we have determined receptor half-life, receptor concentra-
tion, and the rate of receptor synthesis in myogenic cultures
exposed to conditions in whichproteolysis was controlled either
by exclusion of plasminogen, addition of plasmin, addition of
inhibitors, or some combination of these. The results show that
plasmin-catalyzed proteolysis can indeed affect the rate of
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life after sarcoma virus transformation or exposure to tumor
promoters is largely, if not completely, due to formation of
plasmin secondary to enhanced production ofPA . While this
manuscript was in preparation, Libby et al. (11) published a
report concerning the role of lysosomal proteolysis in AChR
metabolism. Their work, which deals with intracellular prote-
olysis, is both relevant and complementary to the experiments
described below .
MATERIALS AND METHODS
Materials
Sephacryl S-200, Sepharose 4B, and Bio-Gel P-2 were obtained from Phar-
maciaFine Chemical Co .(Piscataway,N .J.); 6-aminocaproic acidand diisopropyl
fluorophosphate (DFP) from Aldrich Chemical Inc . (Milwaukee, Wisc) ; uroki-
nase from Leo Pharmaceutical Products (Ballerup, Denmark) ; Trasylol from
BayerA.G. (Wuppertal-Elberfeld,W . Germany) ; glycerol from Fisher Scientific
Co . (Pittsburgh, Pa .) ; aquacide from Calbiochem-Behring Corp . (San Diego,
Calif); and chicken plasma from Pel-Freeze . Leupeptin was a gift from Dr. W.
Troll (New York University Medical Center) . "I-labeled a-bungarotoxin
(12sI-
a-BuTx) (specific radioactivity, 30,000 and 136,000 cpm/pmol, respectively) was
prepared as described by Miskin et al . (14) or was a gift from Dr . B. Fulpius .
Rabbit anti-AChR serum was a gift from Dr . B. Fulpius (University of Geneva,
Switzerland) . Other materials were as described by Miskin et al . (14, 15) .
Methods
CELL CULTURE: Chick embryo myogenic cultures were prepared and
maintained as previously described (15) but the procedures were modified, when
required, to exclude plasminogen, especially in experiments designed to examine
the effects of this zymogen on AChR metabolism. Because plasminogen adheres
to plastic surfaces and a wide variety of macromolecules, it was necessary to use
plasminogen-depleted mediafrom the initial steps in the preparation ofcultures.
Thus, plasminogen-depleted horse serum and fetal bovine serum (FBS) were
used throughout. Passage over lysine-Sepharose columns (Deutsch and Mertz
(31) largely reduced the ability of chicken embryo extract to promote myoblast
fusion, an effect that could not be reversed by the addition of purified chicken
plasminogen. Hence, ordinary chicken embryo extract (final concentration, 3%
[vol/volt) was used during the first4dofculture and then replaced by plasmin-
ogen-depleted embryo extract (1%).
DEPLETION OF PLASMINOGEN FROM CULTURE SUPPLEMENTS: Plas-
minogenwasremoved from culture supplementsaccording toDeutschandMertz
(3) . (a) Sera: 500 nil of horse serum or FBS was centrifuged at 19,000 g for 20
minand loaded into a lysine-Sepharose column (30x 1.5 cm, flow rate of20nil/
h, 4°C) previously equilibrated with 0.1 M phosphate buffer pH 7.4 (buffer A).
The depleted horse serum was dialyzed against native horse serum (5 vol) to
restore low molecular weight substances removed by the column. (b) Embryo
extract : embryo extract was purified in the same way as horse serum after
incubation at 37°C for I h with deoxyribonuclease (20jig/ml), ribonuclease (10
Ag/ml), and hyaluronidase (5 pg/ml) . After passage over lysine-Sepharose the
extract was also dialyzed against an excess of nonpurified embryo extract . (c)
Antisera: 1 nil each of rabbit anti-AChR serum and control rabbit antiserum
(anti-bovine serum albumin) was passed through lysine-Sepharose columns (2
nil) at a flow rate of 1 ml/10 min, at room temperature . Both antisera were heat
inactivated (56°C, 30 min) and stored at -70°C .
PURIFICATION OF CHICKEN PLASMINOGEN :
￿
Chicken plasma (500 ml)
was filtered on gauze mesh to remove fibrin clots, and centrifuged for 30 min at
25,000g . The plasma was then brought to 20% ofsaturation by addition ofsolid
ammonium sulfate, centrifuged for20 min at 10,000 g, left on ice for afew hours,
and recentrifuged to remove additional aggregates. The supernatant was loaded
onto a lysine-Sepharose column (30 x 1 .5 cm, flow rate of 50 ml/h, 4°C)
previously equilibrated with bufferA, and the column waswashed with bufferA
and with 0.3M phosphate buffer, pH 7.4, successively . Plasminogenwas eluted
with 0.2 M 6-aminocaproic acid in buffer A, precipitated at 50% of saturation
with ammonium sulfate, dialyzed against 50 mM ammonium bicarbonate, and
then lyophilized . 20 mg ofplasminogen were dissolved in 2 nil of 0.1 M Tris/
HCl buffer, pH 8.0, containing 0.5 M NaCl, loaded onto a Sephacryl S-200
column (100 x 1.5 cm, flow rate of 20 ml/h, 4°C), and eluted with the same
buffer. The fractions containing plasminogen were pooled, concentrated to 1-2
mg/ml in a dialysis bag by packing in aquacide, dialyzed against PBS, treated
with DFP (13), and stored at -70°C .
ACTIVATION OF PLASMINOGEN : Humanplasminogen (purified accord-
ing to Deutsch and Mertz [31) was diluted to a final concentration of7-10mg/ml
in 0.05M Tris/HCI buffer,pH 8.0, containing 50% glycerol, and incubated with
100 Ploug units/ml urokinase for 24 h at 30°C.
LABELING OF CELL SURFACE ACHR WITH 1251-a-BUTX AND ESTIMA-
TION OF ACHR DEGRADATION RATE : The measurements were made ex-
actly as described by Miskin et al. (15) . For plasminogen-depleted cultures, the
following modification was introduced : .-16 h before labeling ofsurface AChR
the culture medium was changed to Dulbecco's modified Eagle's medium con-
taining l mM additional glutamine and 10% of plasminogen-depleted and acid-
treatedFBS (18) .The same mixture wasused forthe "I-a-BuTx bindingreaction
and throughout the determination of AChR degradation. AChR labeling was
achieved by incubation with 2x 10-8M ` 251-a-BuTx for 60min . Unless otherwise
specified, all incubations were at 37°C . All experimental points are themeans of
duplicate or triplicate cultures .
SYNTHESIS OF NEW SURFACE ACHR :
￿
Measurementoftherateofsynthesis
ofnew surface AChR was as described by Miskin et al. (14), with the following
modification: the culture medium waschanged as described aboveand was also
supplemented with nonradioactive a-BuTx (2 x 10 -e M) for --16 h, to block
surface AChR. Thesame medium was used after removal ofnonradioactive a-
BuTx. All experimental points are themean of duplicate cultures .
RESULTS
Three experimental approaches were used to delineate the
potential role of plasmin in AChR metabolism : (a) cultures
were deprived of plasminogen, thereby blocking the formation
ofplasmin ; these were compared with control cultures in which
the desired level of plasminogen had been restored by addition
ofpure proenzyme; (b) protease inhibitors, capable ofblocking
PA and/or plasmin were added to culture media; (c) plasmin
was added to cultures for various lengths of time . The steady-
state level of receptor, the rate ofreceptor degradation, the rate
of receptor synthesis, or some combination of these, was deter-
mined for each set of conditions .
Effect of Plasminogen on AChR Half-life
Previous work having shown that the tumor-promoter phor-
bol myristate acetate (PMA) both reduced receptor half-life
and increased PA production (14, 15), we explored the effect
of plasminogen on the rates of AChR degradation in both
untreated and PMA-treated cultures . The results of a typical
set of observations are presented in Fig. 1, and the findings
obtained from eight separate experiments are summarized in
Table 1 .
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FIGURE 1 Effect of plasminogen, is-68, and PMA on half-life of
AChR in muscle cultures. Uninfected and is-68 infected companion
cultures were grown at 42° for6d in media containing plasminogen-
depleted horse serum and embryo extract . Medium was then
changed, PMA (50 ng/ml) and/or plasminogen (42 Fig/ml) were
added to some of the cultures, and all cultures were shifted to 37°C .
Determination of AChR half-life was performed in the usual way
beginning 16 h after temperature shift, and when indicated, in the
presence of PMA and/or plasminogen . (O, ") Control without and
with plasminogen, respectively ; (A, A) ts-68 infected without and
with plasminogen, respectively ; (O, /) PMA treated without and
with plasminogen . Surface AChR was, in the same order : 371, 347,
69, 73, 295, and 286 fmol/culture. The numbers indicate the value
of the receptor half-life for each curve .
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177The profiles in Fig. 1 demonstrate that typical decay curves,
with single first-order slopes, were observed under all of the
experimental conditions tested; hence, the presence or absence
of plasminogen or PMA merely altered the rate, but did not
grossly distort the characteristic pattern ofAChR degradation.
Fig. 1 also shows that both sarcoma virus transformation and
PMA accelerated receptor degradation in comparison with the
control, and that the addition ofplasminogen shortened AChR
half-life in allthree types ofculture. These results are reinforced
by the data in Tables I and II. Here it can be seen:
(a) There is a basic rate ofAChR turnover which persists in
the absence of added plasminogen (Table I, column I). Al-
though we could not rigorously exclude every last trace of
plasminogen (see Materials and Methods) it appears unlikely
that the small amounts remaining from the initial supplement
of embryo extract could account entirely for the observed rate
of receptor degradation, especially since the effect of much
larger supplements of plasminogen (column II) was consis-
tently modest.
(b) The addition of plasminogen to control cultures acceler-
ated receptor degradation perceptibly, but only to a limited
extent, in six of eight experiments (compare columns I and II).
The magnitude ofthis effect was compatible with the low levels
of PA production, and hence of plasmin formation, observed
in such cultures (15).
(c) PMA treatment alone (column III) caused only a minor
reduction in receptor half-life. This decrease was less frequent,
occurring in only four ofeight experiments, than that produced
by the addition of plasminogen alone. Since this PMA treat-
ment induces high levels ofPA production (15), the inconsistent
TABLE I
Effect of Plasminogen and PMA on Half-life of AChR in
Muscle Cultures
Half-life of control
￿
Half-life of PMA-
cultures (h)
￿
treated cultures (h)
II/I
￿
III/I
￿
IV/I
Average ratio:
￿
(1 .00)
￿
(0.89)
￿
(0.89)
￿
(0.62)
Plasminogen-depleted cultures were prepared and maintained as described
in Materials and Methods. AChR half-life determination was performed in the
usual way in the presence and absence of PMA and/or plasminogen. When
present, PMA (50 ng/ml) and chicken plasminogen (28 ug/ml in experiment
1, and 42)Fg/ml in experiments 2-8) were first added to the cultures ^-16 h
before labeling AChR with radioactive a-BuTx, and then maintained through-
out the experiment. Culture ages on days of labeling were: 4 and 5 d in
experiments 1 and 2, respectively, 7 d in experiments 3-7, and 8 d in
experiment 8. In experiments 6and 7, cultures were incubated for 5 dat42°C
and then for 1 d at 37°C before labeling with '251-a-BuTx. The numbers in
parentheses represent the ratio of AChR half-life under the particular culture
conditions (Column It, III, or IV) to that in control (column I) . The value for
the control (column 1) wasarbitrarily set at unity for each Pzperiment. When
these data were analyzed by Student's ttests (both separate and pooled data)
groups l, 11, and 111 were not significantly different (P > 0.1), whereas the
difference between IV and 111 (and therefore between IV and 11 or I) was
highly significant (P<0.001).
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TABLE II
Effect of ts-68 on Half-life of AChR in Muscle Cultures
Effect of Plasmin on AChR Turnover
Uninfected and companion ts-68 cultures were incubated at 42°C for 7 d in
media containing plasminogen-depleted horse serum and embryo extract as
described in Materials and Methods. 16 h before AChR was labeled with
radioactive a-BuTx, the medium was changed, chicken plasminogen (42 Pg/
ml) was added to some of the cultures, and the indicated cultures were
shifted to 37°C. Determination of AChR half-life was performed at 37° or
42°C, with or without plasminogen, as indicated. The values in parentheses
represent the ratio of the AChR half-life under the particular conditions to
that of the control, uninfected cultures, in the absence of plasminogen, at 42°
or 37°C, respectively.
effect on receptor degradation might have been due to small
variations in residual plasminogen levels, and thus of plasmin
activity, in the different experiments. It also follows from this
result that proteolysis by PA itself, in the absence of plasmin-
ogen, was not a significant factor in AChR turnover.
(d) Substantial reductions in AChR half-life occurred in all
cultures exposed to both PMA and plasminogen (column IJI).
Thus the PMA-stimulated acceleration of receptor turnover
wasplasminogen dependent and therefore largely, and perhaps
entirety, due to the proteolysic action of plasmin.
The data in Table II present an analogous pattern for
myogenic cultures infected with ts-68. The results of this ex-
periment are complicated by the fact that receptor degradation
increases as a function of increasing temperature (4), thereby
limiting comparisons of the different cultures to those incu-
bated at a single temperature. Here PA production was in-
creased (15) and receptor half-life decreased (14) at 37°C, the
permissive temperature for sarcoma virus transformation. It
can be seen, as in TableI, that small reductions in AChR half-
life occurred when plasminogen was added to control cultures
at both 37° and 42°C, and to the ts-68infected culture at 42°C,
the nonpermissive temperature for transformation. A large
reduction in AChR half-life was observed only at 37°C in the
presence of plasminogen, conditions that ensured the genera-
tion of substantial amounts ofplasmin since PA production is
strongly enhanced by and coupled with transformation.
The plasminogen dependence of the changes in AChR half-
life after ts-68 transformation and exposure to PMA implied
that comparable effects on receptor metabolism should be
produced simply by addition of plasmin. The results of the
four experiments summarized in Table III show that this is the
case. Both concentrations of plasmin tested were well within
the range that can be regarded as physiological, considering
the level of plasminogen in plasma (>200 tLg/ml), and both
markedly shortened half-life when added after receptor was
labeled with 125I_a-BuTx. The effect of plasmin pretreatment
(16 h, 50 1~g/ml) before labeling with 125I-a-BuTx was tested in
companion cultures to those of experiments 2 and 3: this
treatment gave values for AChR half-life intermediate between
those ofthe control and plasmin-treated samples (34 and 40 h,
Experiment
number
Absent
(I)
Plasminogen
Present Absent
(11) (I11)
Present
(1V)
1 32 (1 .00) 32 (1 .00) 32 (1.00) 22 (0.69)
2 34 (1 .00) 29 (0.85) 29 (0.85) 18 (0.53)
3 43 (1 .00) 36 (0.84) 29 (0.81) 22 (0.51)
4 43 (1 .00) 44 (1 .02) 42 (0.98) 37 (0.86)
5 34 (1 .00) 29 (0.85) 27 (0.79) 20 (0.59)
6 40 (1 .00) 33 (0.83) 28 (0.70) 21 (0.53)
7 43 (1 .00) 38 (0.88) 41 (0.95) 26 (0.60)
8 41 (1 .00) 36 (0.88) 42 (1 .02) 27 (0.66)
Half-life (h)
Plasminogen
Temperature Absent Present
Control 420C 25 (1 .00) 20 (0.80)
is-68 42°C 23 (0.92) 21 (0.84)
Control 370C 43 (1 .00) 38 (0.88)
is-68 37°C 43 (1.00) 32 (0.74)TABLE III
Effect of Plasmin and Trasylol on Half-life of AChR in Muscle Cultures
respectively, for experiments 2 and 3); the combination of
plasmin pretreatment, followed by toxin labeling and subse-
quent plasmin treatment yielded half-life values close to those
of the plasmin posttreatment alone. The plasmin effects on
AChR half-life were abolished by the addition of the trypsin
and plasmin inhibitor Trasylol, showing that these were due to
the proteolytic action of the enzyme (Table III). Trasylol itself
was inert with respect to receptor metabolism and, specifically,
did not affect receptor half-life in the absence of plasminogen;
this is evidence that a significant fraction of AChR metabolism
proceeds by a plasmin-independent route.
It was previously observed (14) that when AChR half-life
was modulated by environmental variables such as serum or
embryo extract the ratesofreceptor degradation were matched
by corresponding changes in synthesis to preserve a relatively
constant levelof surface AChR. It was therefore of interest also
to examine the effect of plasmin both on surface AChR con-
centration and on receptor synthesis. The results of such an
experiment are presented in Fig. 2: after a 5-h lag period,
surface AChR decreased progressively for 24 h in the plasmin-
containing culture, reaching a level approximately one third
below that of the control (upper curves). Plasmin is known to
be autolytic and thus to lose its catalytic activity progressively
under conditions of cell culture resembling those used here
(20). The 5-h lag period preceding any measurabledecrease in
surface AChR is therefore noteworthy, since it coincided with
the period of highest plasmin concentration and most intense
proteolytic activity. This suggests that the subsequent reduction
of receptor concentration was due to a process which was
initiated gradually during the first few hours and persisted
thereafter for a longer period, rather than to direct proteolysis
of membrane-bound receptor itself. The concurrent measure-
ment of AChR synthesis (lower curves) showed no significant
difference between the plasmin-treated and control cultures.
The decrease in surface AChR that accompanied plasmin
treatment therefore reflected the increased rate of degradation
(Table III) which, in this case, did not induce any reciprocal
change in receptor synthesis.
A number ofcontrol experiments were performed to test for
other potential sources of artifacts. Since a-BuTx contains a
number of basic amino acid residues that are potential targets
for plasmin action, the decreased half-life might have been due
to direct proteolysis ofa-BuTx in receptor complexes, followed
by toxin dissociation. Had this occurred, the putative toxin
fragments released by such a process should have been detect-
able in the supernatant as peptides of molecular weight inter-
mediate between those of native toxin and iodotyrosine, the
Cultures were grown with plasminogen-depleted horse serum and embryo extract (experiments 1 and 2) or with plasminogen-containing supplements
(experiments 3 and 4) and analyzed for AChR half-life in the presence of the indicated supplements. Supplements were first added to culture medium
immediately after labeling AChR with radioactive a-BuTx. Supplements were maintained throughout the period in which AChR degradation was measured.
Numbers in parentheses represent surface AChR in fmoles per culture.
radioactive degradation product normally produced by meta-
bolic turnover ofreceptor-toxin complexes (4). The data in Fig.
3 show that this was not the case: as in control cultures,
iodotyrosine was essentially the only toxin degradation product
observed in plasmin-treated cultures, a finding which indicates
that plasmin-stimulated degradation proceeds by the lysosomal
pathway. A second possibility, namely, that a rate-limiting
endoproteolytic nick by plasmin, followed by exopeptidase
action due to serum protease, could generate free iodotyrosine
as an a-BuTx degradation product, was excluded by the finding
that plasmin does not attack the toxin.' A third alternative was
that proteolysis by plasmin could have modified the receptor
to increase the rate of dissociation of intact '251-a-BuTx; the
released toxin would in turn have been more or less degraded
either by plasmin outside the cells, or, after pinocytosis, in
some cellular compartment. This possibility is excluded by
three facts: free t25I-a-BuTx, at the concentrations that could
be generated by dissociation of receptor toxin complexes, is
neither internalized nor degraded in myogenic cultures (4, 14),
nor is it attacked by plasmin (Hatzfeld and Miskin, unpub-
lished observations). Moreover, had significant dissociation
and subsequent partial degradation occurred in the supernatant
these should have been detected (in the experiment presented
in Fig. 3), as an increase either of free '251-a-BuTx or of partial
degradation products, but neither was observed. We therefore
conclude that the proteolytic mechanism by which plasmin
accelerates receptor degradation is not based on direct prote-
olysis ofbound or dissociated toxin.
As a further test of protease involvement in AChR metabo-
lism we investigated the effects of the protease inhibitor leu-
peptin. The action of this inhibitor is somewhat complex
because it blocks serine proteases, including plasmin and PA
' The resistance ofa-BuTx to plasmin was demonstrated in the follow-
ing experiment: 500 fmol of 1251-a-BuTx were incubated for 15 h at
37° in 2 ml of Dulbecco's modified Eagle's medium containing the
following supplements: (a) human plasmin (50 pg/ml); (b) human
plasmin (50 pg/ml) plus 10°10 of fetal bovine serum (acid-treated to
destroy protease inhibitors); (c) chicken plasmin (50 pg/ml, generated
as described in Materials and Methods for human plasmin, but using
10-fold more urokinase) plus 10% of acid-treated fetal bovine serum.
At the end ofthe incubation, the samples were reduced by the addition
of dithiothreitol (5 X 10-2 M) and analysed on a Bio-Gel P-2 column
as described in the legend to Fig. 3. All three samples gave identical
profiles in which the bulk of radioactivity emerged, as did authentic
a-BuTx, at the void volume of the column; there wasa small amount
of residual contaminating 1251-, and no evidence of proteolytic frag-
ments in any sample.
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Treatment Medium supplement Exp. 1 Exp. 2
Half-life (h)
Exp. 3 Exp. 4
1 Control 29 (227) 41 (197) 48(388) 42 (198)
2 Trasylol, 5 X 10 -e M - 48 (386) -
3 Trasylol, 2 X 10 -° M - - 42 (195)
4 Plasmin, 25 pg/ml - - 30(396)
5 Plasmin, 50 pg/ml 19 (238) 27 (187) 24 (367)
6 Plasmin, 50Pg/ml+Trasylol, 5 28 (228) 40 (191) 43 (367)
X 10 -e M(22), as well as lysosomal proteases (8, 12) . When added to
cultures in the presence of PMA and/or plasminogen, appro-
priate concentrations of leupeptin invariably prolonged appar-
ent AChR half-life; two examples, representing a control series
in the absence of either PMA or plasminogen, and a set of
cultures exposed to both of these agents, are illustrated in Fig.
4 . Cultures containing either PMA or plasminogen alone
yielded analogous profiles intermediate between and parallel
with the two curves in Fig . 4 . Beginning at -5 x 10-7 M,
increasing concentrations ofleupeptin progressively raised ap-
parentAChR half-life both in control cultures and in cultures
containing PMA and plasminogen . Nevertheless, the difference
in theAChR half-life between the two cultures, which exists in
the absence of leupeptin (Table 1, columns I and It), was
maintained at all concentrations of leupeptin tested . We note
also that the ordinate in Fig. 4 represents a half-life determi-
nation for each point on both curves. Thus the overall process
of receptor degradation follows first-order kinetics throughout
the range of experimental conditions explored here . To obtain
additional information about leupeptin effects, we also meas-
ured both surface AChR and the rate of receptor synthesis
under conditions identical to those for Fig. 4. There was no
change either in the steady-state surface AChR level or in the
rate ofreceptor synthesis and incorporation into plasma mem-
brane during a 24-h period (Fig . 5) . The results confirm the
fmdings described by Libby et al. (11), which were obtained
under slightly different conditions . These findings also repre-
sent a reasonable foundation for the reported intracellular
Hours
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FIGURE 2
￿
Effect of plasmin on surface levels of AChR and on the
synthesis of new surface receptors. Plasminogen-depleted cultures
were used for the experiment. To examine the effect of plasmin on
the levels of surface AChR, human plasmin was first added to some
of the cultures at zero time, and the medium was renewed after 16
h . At different times after the first addition, levels of surface AChR
were measured at the indicated times in some cultures, and the rate
of synthesis of new surface receptors was determined in companion
cultures, likewise in presence and absence of plasmin . In the latter
case, plasmin was first added just after removal of nonlabeled a-
BuTx from culture medium (time 0), and the medium was changed
once after 16 h . Protein was determined by the method of Lowry et
al . (13) . (O---O, 0---") Surface AChR in control and in plasmin-
treated cultures, respectively . (O-O), 0--" ) Synthesis of AChR in
control and plasmin-treated cultures, respectively.
Fraction number
FIGURE 3 Analysis of degradation products of AChR-1251-a-BuTx
complexes from control and plasmin-treated muscle cultures . Ra-
dioactivity released into culture medium in control and plasmin-
treated cultures was analyzed for degradation products of AChR-
"51_a-BuTx complexes by gel filtration on a Bio-Gel P-2 column .
Samples taken from experiment 3 in Table IV (treatments 1 and 4)
were loaded onto a column (25 x 1 cm) previously equilibrated
with 0.5 M ammonium acetate, pH 5.0, at 4°C, and eluted with the
same buffer. (A and 8) Samples containing "5,000 cpm, collected
2-10 h (A) and 10-18 h (8) after labeling of AChR with 1251-a-BuTx .
(C) Samples containing
￿
1,000 cpm collected 18-26 h after labeling .
(D) Samples containing
￿
9,000 cpm, collected 25 h after labeling,
without any change of medium . Solid lines, control ; dashed lines,
plasmin-treated . The recovery of radioactivity applied to the column
was always --100% .(presumably intralysosomal) accumulation, in leupeptin-
treated cells, ofAChR in a form capable of binding a-BuTx
(11) . However, several attempts to obtain evidence also con-
firming this observation failed; leupeptin at concentration of 5
x 10-6 M and 2 x 10-4 M gave no detectable increase of
intracellular toxin-binding components during incubations
lasting up to 38 h.
AChR degradation in various myogenic cultures can be
accelerated by antisera obtained from myasthenic patients and
from animal models of myasthenia produced by injection of
receptor preparations (1, 6, 7) . It was thus ofinterest to establish
whether this method ofmodulating receptor metabolism might
be related to the induction ofPA . We used for this purpose a
high-titer rabbit antiserum raised against highly purified Tor-
pedo marmorata receptor. As seen in Table IV, this antiserum
greatly reduced receptor half-life, but the effect did not depend
on the presence of plasminogen. This is in accord with the
finding that a number of myasthenic sera and other rabbit
antisera directed against Torpedo receptor either failed to in-
crease PA production, or stimulated only minimally (Miskin
and Fulpius, unpublished observations).
DISCUSSION
That plasmin catalyzed proteolysis stimulated AChR degra-
dation in myogenic cultures is established by several lines of
evidence : first, when added at modest concentrations, highly
purified plasmin produced a substantial and persisting accel-
eration of receptor degradation ; second, this effect of plasmin
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FIGURE 4
￿
Effect of leupeptin on AChR degradation in control and
PMA-treated cultures . Plasminogen-depleted cultures were pre-
pared and maintained as described in Materials and Methods . 16 h
before labeling of AChR with radioactive a-BuTx, some of the
cultures were treated with PMA (50 mg/ml), with plasminogen (42
fLg/ml), and/or with different concentrations of leupeptin . The
respective treatments were maintained throughout the period dur-
ing which AChR degradation was being measured . (O) Control
without plasminogen ; (" ) PMA-treated cultures with plasminogen .
Surface AChR was in the range 220-259 and 153-192 fmol/culture
for control and PMA-treated cultures, respectively . Not shown in
the figure : half-lives of control cultures with plasminogen were 34
and 60 h, respectively, in the absence and in the presence of 2 x
10-6 M leupeptin . For PMA-treated cultures without plasminogen,
the half-lives were 42 and58 h, respectively, in absenceandpresence
of leupeptin .
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FIGURE 5
￿
Effect of leupeptinon surface levels ofAChR and on the
rate of synthesis of surface receptors . Cultures were grown with
plasminogen containing horse serum and embryo extract under
standard conditions . Surface AChR levels and the rate of synthesis
of surface AChR were determined in cultures maintained in the
absence and presence of leupeptin (2 x 10-4 M) . In experiments
concerned with rates of AChR synthesis, leupeptin was added
immediately after the removal of nonradioactive a-BuTx (time 0) .
("---" ,O---O) Surface levels of AChR in control and in leupep-
tin-treated cultures, respectively . (0-" , O-O) Synthesis of surface
AChR in control and in leupeptin-treated cultures, respectively .
TABLE IV
Effect of Plasminogen and Rabbit Anti-Torpedo-AChR Serum
On Half-life of AChR in Muscle Cultures
Plasminogen-depleted cultures were prepared and maintained as described
in Materials and Methods . AChR half-life was measured by the standard
procedure using cultures maintained with or without chicken plasminogen
(421ag/ml), rabbit anti-AChR serum, and/or control rabbit serum (70 ,a1/ml
each) . The indicated supplements were first added immediately after labeling
surface AChR with '251-a-BuTx, and then maintained throughout the experi-
ment . Surface AChR was in the range of 201-257 fmol/culture. The values in
parentheses represent the ratio of AChR half-life under the particular condi-
tions to that of the control culture, in the absence of plasminogen or rabbit
serum .
required proteolysis since it was blocked by the potent trypsin
inhibitor Trasylol ; third, the acceleration ofAChR degradation
by sarcoma virus transformation or by PMA was almost com-
pletely plasminogen dependent . Since both of these agents also
markedly enhance PA production (15), it seems safe to con-
clude that the plasmin thus generated was responsible for the
increased rate of receptor turnover.
How might proteolysis by plasmin influence receptor deg-
radation? Although the available evidence is limited, several
facts imply that this perturbation ofAChR turnover is probably
a secondary consequence of altered membrane metabolism
resulting from proteolysis of surface components other than
the receptor itself. Thus, plasmin did not reduce the number of
externally accessible, toxin-binding sites for at least 5 h after
addition to myogenic cultures (Fig . 2), the period during which
plasmin action should be most pronounced . Further, the re-
duced level of surface AChR that was ultimately reached
developed slowly; it coincided with and reflected the acceler-
ated first-order receptor degradation, and therefore did not
HATZFELD ET AL.
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Medium supplement
Half-life
Absent
(h)
Plasminogen
Present
None 42 (1.00) 36 (0.86)
Control rabbit serum 43 (1.02) 37 (0.88)
Rabbit anti- Torpedo-AChR serum 21 (0.50) 19 (0.45)follow the kinetics expected of direct enzymatic inactivation.
These considerations suggest that plasmin did not attack free
AChR. Likewise,judging both from the rate of toxin dissocia-
tion and the spectrum of "'I-toxin degradation products, there
is no evidence that plasmin could attack either the receptor or
toxin components of surface complexes. We conclude tenta-
tively that plasmin probably affects the receptor indirectly, by
modulating some aspect ofmembrane metabolism whichinflu-
ences the rate ofAChR degradation. It is also clearthat AChR
degradation can be modulatedby avarietyof means, including
antisera containing antibodies directed against receptor and
probably other membrane components, and by cross-linking
agents (6, 7); at least some of these effects are not mediated by
membrane proteolysis. Thus, although plasminogenactivation
is not an obligatory factor in all pathways of AChR degrada-
tion, receptor half-life is appreciably shortened when this en-
zymatic system is mobilized by myogenic cells.
Ourdata, taken together with those of Devreotes and Fam-
brough (4) and Libby et al. (11), provide a framework for
visualizing themetaboliccycle of AChR and identifying likely
sites of regulatory modulation. Because receptor degradation
follows overall first-order kinetics, each step in the pathway
must also obey the first-order rate law. With this in mind, a
reasonable minimal sequence would be internalization of sur-
face receptor by formation of endocytic vesicles, followed by
vesicle fusion with lysosomes wherein receptor proteolysis is
thoughtto occur; each of thesestages would conformto a first-
orderprocess. Thefirstcouldbe modulatedby events occurring
at the cell surface, and we propose that plasmin accelerates
internalization by proteolysis of some as yet unidentified
plasma membrane constituent(s). This plasmin-catalyzed re-
action provides an experimentally accessible starting point for
attempting to dissect some of the initial stages in receptor
turnover. Thesecond step in AChR degradation, vesicle fusion
and intralysosomal digestion, is apparently inhibitedby several
protease inhibitors including pepstatin, leupeptin, and trypan
blue, and by other inhibitors of lysosomal functions such as
chloroquine (4, 11). Two of these, leupeptin and trypan blue,
also inhibit plasmin and PA (2, 22), and thus would slow the
reaction rate at both ends of the degradative pathway.
It is probably significant that neither the acceleration of
receptor degradation by proteolysis (plasmin alone, or PMAin
presence of plasminogen) nor its inhibition by leupeptin or
chloroquine (11) produced any change in the rate of AChR
synthesis. Hence, perturbations of the degradative limb of
receptor metabolism, at least by way of the particular agents
tested so far, areapparently notreflectedin changes ofreceptor
synthesis; and the latter process is, therefore, not coupled to
degradation and must be subject to independent regulation.
Moreover, proteolysis by plasmin and by lysosomal enzymes
areboth nonspecific processes, and specific regulation is likely
to occur predominantly at some stage in the biosynthetic
portion of receptor metabolism. Thus the compensating in-
creases observed to accompany accelerated AChR degradation
at early culture age, or stimulated by embryo extract and FBS
(14) appear to depend on additional factors that modulate the
rate of receptor synthesis more directly. Likewise, protease-
catalyzed increase in AChR degradation cannot by itself ac-
count for all of the PMA-stimulated reduction in surface
receptor: the full magnitude of this change is the consequence
of two additive but independent processes, both of which are
due to PMA. One of these is the inhibition of AChR biosyn-
thesis (14) andthesecond is accelerated degradation ofsurface
AChR secondary to proteolysis initiated by PA induction(15).
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We have previously shown that sarcoma virus transforma-
tion andtumor promotersshorten AChR half-life in myogenic
cultures and the present results show that this is achieved by
production of PA, leading to the formation of plasmin. This
effect may be of general significance, since oncogenic viruses
and tumor promoters have been reported to reduce the levels
of receptors for epidermal growth factor (EGF) (10), l-adre-
nergic compounds (17), and insulin (19), and to increase the
turn over of fibronectin (16). Some or allof these phenomena,
and the recent fording that down-regulation of EGF receptors
is serum dependent (21), could be either primary or secondary
consequences ofelevations in activity ofthePA system. Indeed,
since induction of PA synthesis by EGF (9), and down-regu-
lation (21) take place under similar conditions in the same
cells, the decreased cellular sensitivity to EGF may be an
example of a negative feedback response by mediated proteo-
lytic reduction of receptors. All of these observations suggest
that proteolysis generated by high levels of PA production may
influence the metabolism and concentration of surface recep-
tors and, thereby, the hormone responsiveness of neoplastic
cells, a possibility that deserves further study.
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